4th Quarter - Report

POLSINELLI PC for EVERYLIFE FOUNDATION FOR RARE DISEASES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to accelerating the drug approval process for ultra rare diseases [Orphan Product Extensions Now Accelerating Cures & Treatments - OPEN ACT (H.R. 1223/S.1509) -- all provisions

LobbyistCovered position, as disclosed
ROBERT DALEY —
TIM PERRIN —
HARRY ANASTASIOS SPORIDIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1509 (115th), H.R. 1223 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.